Heather Raymon

This profile gathers the share dealings of Heather Raymon in Artiva Biotherapeutics, Inc. In total, 6 filings cover trades dated from 12 September 2024 to 15 February 2026.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 18 February 2026 with a share grant in Artiva Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.